| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 17, 2022 | BONESUPPORT Holding AB (publ) – Publishes full year report 2021 | BONESUPPORT Holding AB (publ) – Publishes full year report 2021
Thu, Feb 17, 2022 08:00 CET Report this content
Lund, Sweden, 08:00 CET, February 17, 2022 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the managem... |
| Feb 10, 2022 | BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for year end report 2021 | BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for year end report 2021
Thu, Feb 10, 2022 10:00 CET Report this content
Lund, Sverige, 10.00 CET, 10 February 2022 – BONESUPPORT HOLDING AB (publ), an emerging leade... |
| Feb 1, 2022 | Change in number of shares and votes in BONESUPPORT Holding AB (publ) | Change in number of shares and votes in BONESUPPORT Holding AB (publ)
Tue, Feb 01, 2022 09:00 CET Report this content
Lund, Sweden, 09:00 CET, 1 February 2022 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the man... |
| Jan 13, 2022 | BONESUPPORT signs distribution agreement with OrthoPediatrics | BONESUPPORT signs distribution agreement with OrthoPediatrics Thu, Jan 13, 2022 15:30 CET
Lund, Sweden, 15:30 CET, 22-01-13 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the c... |
| Dec 30, 2021 | Change in number of shares and votes in BONESUPPORT Holding AB (publ) | Change in number of shares and votes in BONESUPPORT Holding AB (publ) Thu, Dec 30, 2021 12:00 CET
Lund, Sweden, 12:00 CET, 30 December 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone inj... |
| Nov 30, 2021 | Change in number of shares and votes in BONESUPPORT Holding AB (publ) | Change in number of shares and votes in BONESUPPORT Holding AB (publ) Tue, Nov 30, 2021 12:00 CET
Lund, Sweden, 12:00 CET, 30 November 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone inj... |
| Nov 4, 2021 | BONESUPPORT Holding AB (publ) – Publishes Q3 2021 Interim report | BONESUPPORT Holding AB (publ) – Publishes Q3 2021 Interim report Thu, Nov 04, 2021 08:00 CET
Lund, Sweden, 08:00 CEST, November 4, 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injurie... |
| Oct 28, 2021 | BONESUPPORT HOLDING AB (publ) – Interim Report Q3 2021 Invitation to conference call and webcast | BONESUPPORT HOLDING AB (publ) – Interim Report Q3 2021 Invitation to conference call and webcast Thu, Oct 28, 2021 10:00 CET
Lund, Sverige, 10.00 CET, 28 October 2021 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for... |
| Oct 11, 2021 | BONESUPPORT appoints Michael Wrang Mortensen to EVP R&D and Operations | BONESUPPORT appoints Michael Wrang Mortensen to EVP R&D and Operations Mon, Oct 11, 2021 11:00 CET
Lund, Sweden, 11:00 CET, 211011 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, announced today... |
| Sep 30, 2021 | Change in number of shares and votes in BONESUPPORT Holding AB (publ) | Change in number of shares and votes in BONESUPPORT Holding AB (publ) Thu, Sep 30, 2021 12:00 CET
Lund, Sweden, 12:00 CET, 30 September 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone in... |
| Sep 28, 2021 | BONESUPPORT – SUPPLEMENTARY US DENOVO APPLICATION SUBMITTED | BONESUPPORT – SUPPLEMENTARY US DENOVO APPLICATION SUBMITTED Tue, Sep 28, 2021 08:00 CET
Lund, Sweden, 08:00 CET, 28-09-21 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the com... |
| Sep 9, 2021 | Study results on FORTIFY are inconclusive | Study results on FORTIFY are inconclusive Thu, Sep 09, 2021 19:40 CET
Lund, Sweden, 19:40 CET, 09 09 21 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced inconclusive results for the c... |
| Aug 31, 2021 | Change in number of shares and votes in BONESUPPORT Holding AB (publ) | Change in number of shares and votes in BONESUPPORT Holding AB (publ) Tue, Aug 31, 2021 18:00 CET
Lund, Sweden, 18:00 CET, 31 August 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injur... |
| Jul 15, 2021 | BONESUPPORT Holding AB (publ) – Publishes Q2 2021 Interim report | BONESUPPORT Holding AB (publ) – Publishes Q2 2021 Interim report Thu, Jul 15, 2021 08:00 CET
Lund, Sweden, 08:00 CEST, July 15, 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injuries, ... |
| Jun 17, 2021 | BONESUPPORT HOLDING AB (PUBL)
BONESUPPORT : receives “breakthrough device designation” for CERAMENT G for the indication trauma | Lund, Sweden, 10:00 CET, 17 06 21 BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company's antibiotic eluting product CERAMENT G has been categorized as a breakthrough device... |
| May 20, 2021 | BULLETIN FROM THE ANNUAL SHAREHOLDERS’ MEETING IN BONESUPPORT HOLDING AB ON 20 MAY 2021 | BULLETIN FROM THE ANNUAL SHAREHOLDERS’ MEETING IN BONESUPPORT HOLDING AB ON 20 MAY 2021 Thu, May 20, 2021 14:00 CET
Lund, Sweden, 14:00 CET, 20 May 2021 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injurie... |
| BONESUPPORT appoints Michael Roth as General Manager & Executive Vice President Commercial Operations North America | Lund, Sweden, 17.00 CET, 29 April 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries announces a change in its leadership team that will take place June 1, 2020. Michael Roth starts in the position... |
| BONESUPPORT HOLDING AB signs an agreement on a working capital facility of SEK 60 million | Lund, Sweden, 12:00 pm CET, 31 January 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company has signed an agreement with Skandinaviska Enskilda Banken (SEB) for a cr... |
| BONESUPPORT awarded Synthetic Implantable Products agreement with Premier | —– This press release has been modified to comply with the Premier IR guidelines —–
Lund, Sweden, 13.00 CET, 20 April 2021 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, has been awarded a group p... |
| BONESUPPORT HOLDING AB (PUBL) – PUBLISHES FULL YEAR REPORT 2021 | Lund, Sweden, 08:00 CET, February 17, 2022 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today publishes the interim report for the fourth quarter 2021 and the full year 2021.
ST... |
| BONESUPPORT HOLDING AB (publ) – Interim Report Q1 2021 Invitation to conference call and webcast | Lund, Sverige, 10.00 CET, 29 April 2021 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, will publish its Interim Report Q1 2021, on the 6 May at 08.00 am CET.
The Company will hold... |
| BONESUPPORT HOLDING AB (publ) – Interim Report Q3 2021 Invitation to conference call and webcast | Lund, Sverige, 10.00 CET, 28 October 2021 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, will publish its Interim Report Q3 2021, on the 4 November at 08.00 am CET.
The Company wi... |
| Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) | Lund, Sweden, 16:00 CET, 31 August 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votes. During August, the number of shar... |
| BONESUPPORT moves to Mid Cap | Lund, Sweden, 11.00 CET, Dec 17, 2020 BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, will be moved to the Mid Cap segment on Nasdaq Stockholm from 4 January 2021.
Based on Nasdaq Nordic’s recent ann... |
| Study results on FORTIFY are inconclusive | Lund, Sweden, 19:40 CET, 09 09 21 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced inconclusive results for the company’s Investigational Device Exemption (IDE) study; FORTIFY. The pr... |
| BONESUPPORT signs distribution agreement with OrthoPediatrics | Lund, Sweden, 15:30 CET, 22-01-13 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company has entered into a distribution agreement with OrthoPediatrics Corp., a leader in t... |
| BONESUPPORT starts its own sales organization in the Netherlands | Lund, Sweden, 15.00 CET, 8 June 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announces that the company is from 1 July 2020 starting direct sales within the Netherlands.
“We have a pr... |
| BONESUPPORT receives “breakthrough device designation” for CERAMENT G for the indication trauma | Lund, Sweden, 10:00 CET, 17 06 21 BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company’s antibiotic eluting product CERAMENT G has been categorized as a breakthrough device... |
| Delays within FDA postpones CERAMENT G De Novo decision | Lund, Sweden, 08:00 CET, February 28, 2022 –BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that due to internal delays at the U.S. Food and Drug Administration (FDA), the agency has i... |
| BONESUPPORT HOLDING AB (publ) – Full Year Report 2019 – invitation to conference call and webcast | Lund, Sweden, 08.00 am CET, 19 February 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, will publish its Full Year Report 2019, on the 26 February at 08.00 am CET.
The Company... |
| BONESUPPORT HOLDING AB (publ) – Publishes Q2 2020 Interim report | Lund, Sweden, 08:00 am CET, July 17, 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2020.
STRONG SALES GROWTH IN THE... |
| BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for year end report 2021 | Lund, Sverige, 10.00 CET, 10 February 2022 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, will publish its year end report for 2021, on the 17 February 2022 at 08.00 am CET.
The C... |
| BONESUPPORT HOLDING AB presents health economic evidence | Lund, Sweden, 19.00 CET, 18 September 2019 – BONESUPPORT HOLDING AB, listed on Nasdaq Stockholm – an emerging leader in orthobiologics for the management of bone voids announced today that health economic data was presented during the EBJIS... |
| Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) | Lund, Sweden, 12:00 pm CET, 31 March 2021 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votes. During March, the number of sha... |
| BONESUPPORT HOLDING AB – Full Year Report 2020 – invitation to conference call and webcast | Lund, Sweden, 10.00 am CET, 10 February 2021 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, will publish its Full Year Report 2020, on 17 February 2021 at 08.00 am CET.
The Compan... |
| BONESUPPORT HOLDING AB (publ) – Interim Report Q3 2020 – invitation to conference call and webcast | Lund, Sweden, 10.00 am CET, 28 October 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, will publish its Interim Report Q3 2020, on 5 November at 08.00 am CET.
The Company will... |
| Bulletin from the annual shareholders’ meeting in BONESUPPORT HOLDING AB on 19 May 2020 | Lund, Sweden, 12.00 CET, 19 May 2020 – BONESUPPORT HOLDING AB, an emerging leader in orthobiologics for the management of bone injuries, today announces that the annual shareholders’ meeting was held in the company on this day and that all ... |
| BONESUPPORT FORTIFY PATIENT ENROLLEMENT FINALIZED EARLIER THAN ORIGINAL PLAN | Lund, Sweden, 16.30 CET, 15 June 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the enrollment of the FORTIFY study on CERAMENT® G has been completed with 198 subjects enr... |
| BONESUPPORT Holding AB publishes Annual Report 2020 | Lund, Sweden, 16:00 CET, 13 April 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injuries, announces that the Annual Report for 2020 is now available as a pdf on the group’s web page, w... |
| BONESUPPORT’S FDA NOTIFICATION: APPROVAL ON DENOVO PATHWAY FOR CERAMENT G WILL REQUIRE ADDITIONAL DATA AND CLARIFICATIONS | Lund, Sweden, 14:30 CET, 27 02 21 –BONESUPPORT ™, a leading company active in orthobiology for the treatment of skeletal injuries, today announced that the company has received a notification from the US Food and Drug Administration (FDA) t... |
| BONESUPPORT HOLDING AB (publ) – Interim Report Q2 2021 Invitation to conference call and webcast | Lund, Sverige, 10.00 CET, 8 July 2021 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, will publish its Interim Report Q2 2021, on the 15 July at 08.00 am CET.
The Company will hold... |
| BONESUPPORT Holding AB (publ) – Publishes Q3 2021 Interim report | Lund, Sweden, 08:00 CEST, November 4, 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today publishes the interim report for the third quarter 2021.
BEST SALES QUARTER TO DATE... |
| BONESUPPORT – SUPPLEMENTARY US DENOVO APPLICATION SUBMITTED | Lund, Sweden, 08:00 CET, 28-09-21 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company has submitted a supplementary De Novo application to the US Food and Drug Administr... |
| BONESUPPORT HOLDING AB (PUBL) – PUBLISHES Q2 2021 INTERIM REPORT | Lund, Sweden, 08:00 CEST, July 15, 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2021.
58% SALES GROWTH IN CONSTANT... |
| Updated CERAMENT BONE VOID FILLER (BVF) instructions for use for the US market | Lund, Sweden, 15:00 CET, 19 October 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, announces that the company, through a 510 (k) to the Food and Drug Administration (FDA), has updated its CERA... |
| BONESUPPORT HOLDING AB (publ) – Publishes Full year report 2020 | Lund, Sweden, 08:00 am CET, 17 February 2021 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today publishes the interim report for the fourth quarter and the full year 2020.
STR... |
| Change in the management team | Lund, Sweden, 17:00 PM CET, 12 February 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries announces a change in its management team. Patrick O’Donnell will leave BONESUPPORT and his role as Genera... |
| Strong CERAMENT data published in Science Advances | Lund, Sweden, 15.00 CET, Nov 30, 2020 BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that new preclinical data has been published in one of the highest ranked research journals, Scien... |
| BONESUPPORT HOLDING AB (publ) – Interim Report Q1 2020 – invitation to conference call and webcast | Lund, Sweden, 08.00 am CET, 29 April 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, will publish its Interim Report Q1 2020, on 8 May at 08.00 am CET.
The Company will hold a... |
| BONESUPPORT HOLDING AB (publ) – Interim Report Q2 2020 – invitation to conference call and webcast | Lund, Sweden, 08.00 am CET, 9 July 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, will publish its Interim Report Q2 2020, on 17 July at 08.00 am CET.
The Company will hold a... |
| BONESUPPORT appoints Fergus MacLeod as General Manager and Executive Vice President Commercial Operations EUROW | Lund, Sweden, 16:00 CET, November 12 2019BONESUPPORT™ an emerging leader in orthobiologics for the management of bone injuries, announces changes in its leadership team that will take place November 18, 2019.
Fergus MacLeod starts in the p... |
| BONESUPPORT HOLDING AB (publ) – Publishes Q3 2019 Interim report | Lund, Sweden, 7 November 2019 08.00 am CET, – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone voids, today publishes the interim report for the third quarter 2019.
BONESUPPORT’S BEST QUARTER E... |
| BONESUPPORT HOLDING AB (publ) – Q3 2019 Interim Report – invitation to conference call and webcast | Lund, Sweden, 08.00 am CET, 30 October 2019 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone voids, will publish its Q3 2019 interim report on the 7 November 2019 at 08.00 am CET.
The Company... |
| BONESUPPORTTM CERTiFy STUDY ON CERAMENT® BONE VOID FILLER NOW PUBLISHED IN THE JOURNAL OF BONE AND JOINT SURGERY | Lund, Sweden, 08:45 CET, December 9 2019 BONESUPPORTTM, an emerging leader in orthobiologics for the management of bone injuries, today announced the publication of the Level I clinical study CERTiFy in the highly ranked Journal of Bone and... |